Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trimetazidine as an Adjunct to Enhance Clopidogrel Response: The TRACER Study.

NCT03603249 is registered in ClinicalTrials.gov with The University of The West Indies as lead sponsor.

NCT NCT03603249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03603249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trimetazidine as an Adjunct to Enhance Clopidogrel Response: The TRACER Study.
Lead sponsor
The University of The West Indies
Phase
Phase 2
Overall status
Completed
Start date
July 1, 2018
Completion date
April 1, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

platelet dysfunction due to drugs